I~ , 3 ~~f 7126 1 TN THE CIRCUIT COURT FOR BALTIMORE CITY 2 3 IN RE : BALTIMORE CITY * April 5, 1994 4 ASBESTOS LITIGATION * Trial Cluster 5 * Judge Edward 6 RALPH 1) .

JFS T: Toxicology and Chemical Food Safety Assessment of Potential Human Health Risks Posed by Benzene in Beverages L.C.

Bone Marrow Transplantation, (1998) 21, 11011107 1998 Stockton Press All rights reserved 02683369/98 $12.00 http://www.stockton-press.co.uk/bmt Long-term follow-up after high-dose therapy for high-risk multiple myeloma B Barlogie1, S Jagannath1, S Naucke1, S Mattox1, D Bracy1, J Crowley2, G Tricot1 and R Alexanian3 1Myeloma and Transplantation Research Center and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR; 2Southwest Oncology Group Statistical Center, Seattle, WA; and 3UT MD Anderson Cancer Center, Houston, TX, USA Summary: Between 1985 and 1990, 133 patients with advanced multiple myeloma (MM) (74% resistance; 41% resistant relapse, RR) were treated with five high-dose therapy (HDT) regimens including: melphalan 100 mg/m2 (MEL 100) (46 patients); MEL 100 plus GM-CSF (24 patients); MEL 140 plus autologous bone marrow transplantation (ABMT) (eight patients); MEL 140 plus TBI 850 cGy plus ABMT (37 patients); and thiotepa 750 mg/m2 (THIO 750) TBI 850 cGy plus ABMT (18 patients).

Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2010, Article ID 365318, 7 pages doi:10.1155/2010/365318 Research Article Trisomy 14 as a Sole Chromosome Abnormality Is Associated with Older Age, a Heterogenous Group of Myeloid Neoplasms with Dysplasia, and a Wide Spectrum of Disease Progression Wei Cui, Carlos E.

Occupational Airways Vol. 5 No. 2 December 1999 Indoor Air Quality and Respiratory Disease, An Increasing Threat to Teachers clinically defined and can be attributed to the indoor air environment.

I 212.

Mesothelioma 235 Tuesday, 12 August 1997 ORAL SESSION Mesothelioma 10:30-12:30 920* Environmental exposure to crocidolite and lung cancer J.

American Journal of Epderridogy .

Vol. 7, 429-433, May 1998 Cancer Epidemiolor, Biomarkers & Prevention 429 Tobacco Use in Relation to Renal Cell Carcinoma1 Jian-Min Manuela Ronald Yuan,2 J.

FUNDAMENTAL AND APPLIED T O X I ~ 1~8.3Y0-39 ( I 992) Dermal Absorption of Dilute Aqueous Chloroform, Trichloroethylene, and Tetrachloroethylene in Hairless Guinea Pigs w.KENNETH T.

wind while Nelson Stake, man | Bger of the field was prepar-' of (he cars wpre demolished.

ARiaG-oom VAPOR PRESSURE /fc-2.

CLIENT PRIVATE AR3X-0ia PROTOCOL TITLE: Metabolism of T-6292, T-6293, T-6294, and T-6295 by Rat and Human Hepatocytes SRI Study No.

Quality Assurance Project Plan Multi-City Study Sampling Task (N100672) BACK TO MAIN Amendment 2 to Revision No.: 1 Effective Date: July 20, 1999 Page 1 o f \ l Amendment 2 to the Quality Assurance Project Plan and Associated SOP's for Empirical Human Exposure Assessment Multi-City Study Sampling Task To July 23,1999 Prepared by Battelle Marine Sciences Laboratory 1529 West Sequim Bay Road Sequim, WA 98382 360-681-3660 APPROVALS 3 ifd Gunster Sampling Task Leader Rosanna Buhl Battelle Sampling Task QA Officer 3 * 1 QMA* tjtyL de'----- --- ^ MMaarrcciaNishiolra y ^ Buaaititcenllce rPiruojjceucat iMvianuagceir 0 ^ u s a n Abogy Battelle Program QA Officer ___ jz iii Date 7 8-a~7-qq Date j/so /o / Date ns#5 *>/ **,+ < * * 1 ^ Date -f S y - t.

BACK TO MAIN ACUTE TOXICITY TO AQUATIC INVERTEBRATES (DAPHNIA MAGNA) TEST SUBSTANCE_________________________________________ Identity: Perfluorooctanoic acid, tetrabutylammonium salt; may also be referred to as PFOA tetrabutylammonium salt, tetrabutylammonium perfluorooctanoate, or as a major component of L-13492.